Supplier Management for Device Makers and Drugmakers: Qualification, Contracts and Audits Course (ONLINE EVENT: February 26-27, 2025)
The "Supplier Management for Device makers and Drugmakers: Qualification, Contracts and Audits Course" training has been added to ResearchAndMarkets.com's offering. This 2-day course will cover ...
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...
Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...
Ultragenyx Pharmaceutical Inc. (RARE) Q4 2024 Earnings Call Transcript
Good afternoon, and welcome to the Ultragenyx Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only-mode. At the end of the prepared ...
60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
The aggregate gross proceeds to the Company from the offering were approximately $1.075 million, before deducting the placement agent fees and other offering expenses payable by the Company. The total ...
Fierce Healthcare6d
Hims & Hers' Super Bowl ad turns up the heat on GLP-1 battle
Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...
Valeo Pharma announces the closing of a share purchase agreement with Xediton Pharmaceuticals Inc.
CNW/ - Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, announced today that it has closed a share purchase agreement ...
PharmiWeb8d
Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations
CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in ...
Medicus Pharma Ltd: Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is currently ...
Agios Pharmaceuticals: Liver Toxicity Issues May Threaten Thalassemia Approval (Rating Downgrade)
Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.
Business Today22d
Nippon India Pharma Fund - Direct Plan - Growth Plan
The risk level of Nippon India Pharma Fund - Direct Plan ... the AUM of Nippon India Pharma Fund - Direct Plan - Growth Plan The assets under Management (AUM) of Nippon India Pharma Fund ...